White House and congressional staff from both parties are discussing legislation that would create an out-of-pocket cap on drug costs for Medicare Part D beneficiaries, individuals briefed on the discussions told BioCentury.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,